Deep brain stimulator ventral electrode up to 3 mA: Clinical Trials

1 trial of Deep brain stimulator ventral electrode up to 3 mA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Deep brain stimulator ventral electrode up to 3 mA: new trials by email Literature Review of Deep brain stimulator ventral electrode up to 3 mA trials Research Report on Deep brain stimulator ventral electrode up to 3 mA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome
Deep brain stimulator ventral electrode up to 2 mA, Deep brain stimulator ventral electrode up to 3 mA, Deep brain stimulator dorsal electrode up to 2 mA - Tourette's Syndrome
Phase 1 / Phase 2WithdrawnThe University of Western Australia2013-03-012021-05-18

Conditions studied

Tics (1)  ·  Tourette Syndrome (1)

Sponsors

The University of Western Australia (1)

Countries

Australia (1)

Top investigators

Christopher Lind, FRACS (1)